Cluster 4/5 was treated with the dual ICI regimen of ipilimumab plus nivolumab. This arm remains open to accrual. Clusters 3, 6, and 7 were excluded from the study. Additional secondary endpoints are ...
Unsupervised clustering results combining the results of RNA-seq and metabolome analysis. News organizations may use or redistribute this image, with proper attribution, as part of news coverage of ...
RNA sequencing (RNA-seq) is a powerful tool in diagnosing Mendelian disorders, but the optimized sequencing depth for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback